Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arcus Biosciences Inc (NY: RCUS ) 17.69 +0.03 (+0.17%) Official Closing Price Updated: 4:10 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 654,284 Open 17.71 Bid (Size) 16.49 (5) Ask (Size) 18.75 (5) Prev. Close 17.66 Today's Range 17.38 - 18.06 52wk Range 12.95 - 25.47 Shares Outstanding 91,300,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Arcus Biosciences to Participate in Two Upcoming Investor Conferences August 21, 2024 From Arcus Biosciences Via Business Wire Breaking Down Arcus Biosciences: 4 Analysts Share Their Views August 09, 2024 Via Benzinga Performance YTD -10.11% -10.11% 1 Month +22.25% +22.25% 3 Month +5.61% +5.61% 6 Month +7.80% +7.80% 1 Year -5.95% -5.95% More News Read More RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 Via InvestorPlace Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update August 08, 2024 From Arcus Biosciences Via Business Wire Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors August 01, 2024 From Sagimet Biosciences Inc. Via GlobeNewswire Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences July 08, 2024 Via Benzinga Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update July 25, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants July 09, 2024 From Arcus Biosciences Via Business Wire Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia July 08, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants June 25, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants June 11, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers June 10, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 06, 2024 From Arcus Biosciences Via Business Wire After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies June 03, 2024 Via Benzinga Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer June 02, 2024 From Gilead Sciences, Inc. Via Business Wire Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers June 01, 2024 From Gilead Sciences, Inc. Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants May 24, 2024 From Arcus Biosciences Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session May 24, 2024 Via Benzinga Arcus Biosciences Announces New Employment Inducement Grants May 09, 2024 From Arcus Biosciences Via Business Wire RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update May 08, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024 May 02, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting April 24, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update April 23, 2024 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants April 09, 2024 From Arcus Biosciences Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
